<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28838" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Seizure Precautions</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Al Sawaf</surname>
            <given-names>Abdullah</given-names>
          </name>
          <aff>SIU</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Arya</surname>
            <given-names>Kapil</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Murr</surname>
            <given-names>Najib I.</given-names>
          </name>
          <aff>South IL Sch of Med, Memorial Med Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Abdullah Al Sawaf declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kapil Arya declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Najib Murr declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28838.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>A common, well-accepted clinical axiom&#x000a0;in neurology is "seizures beget seizures." Therefore, seizure prevention, vigorous follow-up, and early therapy are key to success. More importantly, early treatment is not only more effective, but it also stops progression to status epilepticus. Every time seizures occur, it causes neurological dysfunction despite adequate oxygenation. Thus, it is vital to establish seizure precautions daily.<xref ref-type="bibr" rid="article-28838.r1">[1]</xref><xref ref-type="bibr" rid="article-28838.r2">[2]</xref><xref ref-type="bibr" rid="article-28838.r3">[3]</xref><xref ref-type="bibr" rid="article-28838.r4">[4]</xref>&#x000a0;One factor when considering seizure precautions is knowledge of triggers and precipitating factors. Even though non-compliance with medications is&#x000a0;1 of the most common causes of&#x000a0;breakthrough&#x000a0;seizures, all caregivers and healthcare workers should examine these individuals for any underlying metabolic or infectious&#x000a0;triggers.<xref ref-type="bibr" rid="article-28838.r5">[5]</xref><xref ref-type="bibr" rid="article-28838.r6">[6]</xref><xref ref-type="bibr" rid="article-28838.r7">[7]</xref><xref ref-type="bibr" rid="article-28838.r8">[8]</xref>&#x000a0;One should consider fever or any abnormal laboratory parameter as a cause in patients with therapeutic drug levels. Substance abuse screening is important in the youth. Imaging studies and electroencephalogram (EEG) are important to establish the risk of seizure recurrence. In almost all cases, the prehospital care of seizure patients is supportive. Most seizures only last a few seconds or minutes, especially the simple febrile seizures in children.</p>
        <p>Initial considerations for patients with an ongoing seizure:</p>
        <list list-type="bullet">
          <list-item>
            <p>If the individual continues to have seizures in the emergency room, the one should follow the ABCs (airway, breathing, circulation)</p>
          </list-item>
          <list-item>
            <p>Administer oxygen if the individual is in status epilepticus, is cyanotic, or is in respiratory distress. Some individuals may require rapid sequence intubation, but one should only use a short-acting neuromuscular blocker to avoid masking the seizure activity</p>
          </list-item>
          <list-item>
            <p>Check finger stick blood glucose and replace if &#x0003c;50 mg/dl<xref ref-type="bibr" rid="article-28838.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Obtain&#x000a0;a toxicology screen&#x000a0;and anti-convulsant drug levels (if appropriate).</p>
          </list-item>
          <list-item>
            <p>If the patient is intubated and paralyzed, consider EEG monitoring to determine if there is still ongoing seizure activity</p>
          </list-item>
          <list-item>
            <p>All patients with an active seizure should have&#x000a0;2 large-bore intravenous lines. Administer intravenous glucose and thiamine promptly. If the patient has signs of an infection, get cultures and consider the use of antibiotics</p>
          </list-item>
        </list>
        <p>The key aim of treatment is to control the seizure before any significant neuronal damage occurs, usually between 20 to 60 minutes. Anoxia and central nervous system (CNS) infections correlate with a high mortality rate in status epilepticus.</p>
      </sec>
      <sec id="article-28838.s2" sec-type="Function">
        <title>Function</title>
        <p>
<bold>Ensuring Safety Precautions</bold>
</p>
        <p>Both the caregiver and the healthcare provider have an important duty in ensuring the safety of the patient with seizures. It is important to understand that although lifestyle changes and safety precautions are needed, one should avoid becoming too controlling and rigid. People with epilepsy also need to live a good-quality life that offers independence.<xref ref-type="bibr" rid="article-28838.r9">[9]</xref><xref ref-type="bibr" rid="article-28838.r10">[10]</xref><xref ref-type="bibr" rid="article-28838.r11">[11]</xref><xref ref-type="bibr" rid="article-28838.r12">[12]</xref></p>
        <p>
<italic toggle="yes">
<bold>During the Seizure</bold>
</italic>
</p>
        <list list-type="order">
          <list-item>
            <p>First, ensure adequate ventilation and place patients on the floor on their left side&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Loosen clothing around the neck and ensure the airway is patent. If the patient is clenching the teeth, do not force the mouth open with any object, as this can cause severe damage</p>
          </list-item>
          <list-item>
            <p>Remove all hazardous items from the environment. The patient may be oblivious to what's happening and may not even know what he or she is doing.</p>
          </list-item>
          <list-item>
            <p>If the patient is confused and wandering, either gently guide him/her away and block access to outside areas</p>
          </list-item>
          <list-item>
            <p>Reassure the individual and be comforting</p>
          </list-item>
          <list-item>
            <p>Call 911. In most cases, the seizure ends before EMS arrives. However, there are cases when seizures may last over 3 to 5 minutes. Or the individual may have developed breathing difficulties or severe injuries. If a pregnant patient or a person with diabetes develops a seizure, it is prudent to call an ambulance.</p>
          </list-item>
          <list-item>
            <p>Finally, if the patient does not regain full consciousness, then call EMS. Most patients remain confused for about 45 to 90 minutes after a seizure, so you must use judgment in calling for help.</p>
          </list-item>
          <list-item>
            <p>Avoid restraints, but make sure the patient is in a bed with padded side rails</p>
          </list-item>
          <list-item>
            <p>Place the individual in a lateral position with the neck slightly flexed; this helps the saliva drain from the mouth and prevents the tongue from falling backward</p>
          </list-item>
          <list-item>
            <p>Remove all nearby furniture and other hazards from the area</p>
          </list-item>
          <list-item>
            <p>Provide verbal assurance as the individual is regaining consciousness</p>
          </list-item>
          <list-item>
            <p>Provide the patient with privacy if possible</p>
          </list-item>
          <list-item>
            <p>Call for help and start treatment as ordered by the caregiver</p>
          </list-item>
        </list>
        <p>When a seizure occurs, it is important to note:</p>
        <list list-type="order">
          <list-item>
            <p>Date, time, and duration of the seizures</p>
          </list-item>
          <list-item>
            <p>Level of activity at the time of the seizure</p>
          </list-item>
          <list-item>
            <p>Level of mental status (confused, excited, dazzled, unresponsive, or conscious)</p>
          </list-item>
          <list-item>
            <p>Presence of aura</p>
          </list-item>
          <list-item>
            <p>What type of body movements, which part?</p>
          </list-item>
          <list-item>
            <p>How did the seizure progress? Symmetrical, unilateral, or bilateral?</p>
          </list-item>
          <list-item>
            <p>What type of motor activity? Myoclonic, clonic, tonic, posturing, dystonic</p>
          </list-item>
          <list-item>
            <p>Eye movements, deviation, open/closed, flickering of eyelids, nystagmus</p>
          </list-item>
          <list-item>
            <p>Twitching</p>
          </list-item>
          <list-item>
            <p>Head-turning</p>
          </list-item>
          <list-item>
            <p>Respiratory, rate rhythm</p>
          </list-item>
          <list-item>
            <p>Heart rate and rhythm</p>
          </list-item>
          <list-item>
            <p>Skin temperature: cold, warm, cyanosis</p>
          </list-item>
          <list-item>
            <p>Diaphoresis</p>
          </list-item>
          <list-item>
            <p>Gastrointestinal vomiting, nausea, diarrhea</p>
          </list-item>
          <list-item>
            <p>Eyes pupillary size, symmetry, reaction to light</p>
          </list-item>
          <list-item>
            <p>Sensation, hallucinations</p>
          </list-item>
          <list-item>
            <p>Any other unusual behavior</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">
<bold>After the Seizure (Postictal Stage)</bold>
</italic>
</p>
        <p>After a seizure, most patients experience confusion, fatigue, muscle pain, or a headache. Thus, one should permit the individual to sleep. For the next few days, reassurance is essential. Being calm and helping reorient the person is also of importance. Most seizures are painless and end spontaneously. Seizures are not harmful to others but can lead to complications such as stress on the lungs, brain and the heart. Individuals with prior lung problems may develop labored breathing and respiratory distress. Thus, one may need to administer oxygen.</p>
        <p>Once the seizure has stopped, record&#x000a0;the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Vital signs</p>
          </list-item>
          <list-item>
            <p>Presence of gag reflex</p>
          </list-item>
          <list-item>
            <p>Presence of a headache, character, location duration, and severity</p>
          </list-item>
          <list-item>
            <p>Bowel or bladder incontinence</p>
          </list-item>
          <list-item>
            <p>Any visible injury to the skin, joints, or face</p>
          </list-item>
          <list-item>
            <p>Any residual neurological deficits</p>
          </list-item>
          <list-item>
            <p>Change in behavior</p>
          </list-item>
          <list-item>
            <p>Mental status, confused, anxious</p>
          </list-item>
          <list-item>
            <p>Disturbance in speech</p>
          </list-item>
          <list-item>
            <p>Coordination of movements</p>
          </list-item>
          <list-item>
            <p>Weakness</p>
          </list-item>
          <list-item>
            <p>Level of consciousness</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Conduct a Postictal Exam</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Ask what the individual was doing before the seizure</p>
          </list-item>
          <list-item>
            <p>Was this the first seizure</p>
          </list-item>
          <list-item>
            <p>Ask for the presence of&#x000a0;any other illness</p>
          </list-item>
          <list-item>
            <p>Determine any trigger factors</p>
          </list-item>
          <list-item>
            <p>Ask if the patient had an excess consumption of coffee, alcohol</p>
          </list-item>
          <list-item>
            <p>Excessive hydration</p>
          </list-item>
          <list-item>
            <p>Fever</p>
          </list-item>
          <list-item>
            <p>Any recent head trauma</p>
          </list-item>
          <list-item>
            <p>Concurrent infection</p>
          </list-item>
          <list-item>
            <p>Overexertion</p>
          </list-item>
          <list-item>
            <p>Sleep deprivation</p>
          </list-item>
          <list-item>
            <p>Mood alterations (anger, anxiety, depression, stress)</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Check Blood Work for the Following Triggers</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Hyponatremia</p>
          </list-item>
          <list-item>
            <p>Hypocalcemia</p>
          </list-item>
          <list-item>
            <p>Hypomagnesemia</p>
          </list-item>
          <list-item>
            <p>Dehydration</p>
          </list-item>
        </list>
        <p>
<bold>Medication-Related Triggers</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>A recent change in dose, the frequency of anti-seizure medication</p>
          </list-item>
          <list-item>
            <p>Alcohol or sedative withdrawal</p>
          </list-item>
          <list-item>
            <p>Use of CNS stimulants, including caffeine&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Use of antidopaminergic agents</p>
          </list-item>
          <list-item>
            <p>Use of atypical antipsychotics like clozapine</p>
          </list-item>
          <list-item>
            <p>Use of antidepressants like bupropion</p>
          </list-item>
          <list-item>
            <p>Use of cyclosporine</p>
          </list-item>
          <list-item>
            <p>Use of quinolone or imipenem/cilastatin</p>
          </list-item>
          <list-item>
            <p>Exposure to any toxins</p>
          </list-item>
        </list>
        <p>
<bold>Environmental&#x000a0;and Hormonal Triggers</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Exposure to loud music</p>
          </list-item>
          <list-item>
            <p>Flashing lights</p>
          </list-item>
          <list-item>
            <p>Pregnancy (more likely to be protective)</p>
          </list-item>
          <list-item>
            <p>Menstruation</p>
          </list-item>
          <list-item>
            <p>Olfactory stimuli: Specific odors</p>
          </list-item>
          <list-item>
            <p>Ovulation</p>
          </list-item>
        </list>
        <p>
<bold> Changes in Activity, Lifestyle, and Restrictions</bold>
</p>
        <p>One of the major problems with recommending seizure precautions is the unpredictability of the recurrence. The onus is on the healthcare provider to discuss the following seizure precautions in patients diagnosed with seizures:</p>
        <list list-type="bullet">
          <list-item>
            <p>Working at heights</p>
          </list-item>
          <list-item>
            <p>Climbing tall structures</p>
          </list-item>
          <list-item>
            <p>Driving</p>
          </list-item>
          <list-item>
            <p>Cooking using the oven or a fire</p>
          </list-item>
          <list-item>
            <p>Using heavy machinery and other power tools</p>
          </list-item>
          <list-item>
            <p>Taking a bath unsupervised</p>
          </list-item>
          <list-item>
            <p>Swimming&#x000a0;unattended</p>
          </list-item>
        </list>
        <p>Providers must discuss and document these seizure precautions to prevent any issues, including future litigation by the family members. The problem with seizure precautions is that not all seizure patients are alike. Some may only have nocturnal epilepsy, and thus, one needs to use judgment in recommending safety maneuvers. For example, patients who practice certain sports like biking and skiing, among others, should wear a helmet to prevent head traumas.</p>
      </sec>
      <sec id="article-28838.s3" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Drug management of Patients with Active Seizures</bold>
</p>
        <p>The drugs of choice for patient management of active seizures are the benzodiazepines. One may administer intravenous lorazepam or diazepam. If the patient has no intravenous access, intramuscular midazolam, buccal/nasal midazolam, or rectal diazepam are other options. Intravenous lorazepam is&#x000a0;more effective than intravenous diazepam in inducing cessation of the seizure and preventing recurrent seizures.<xref ref-type="bibr" rid="article-28838.r13">[13]</xref>&#x000a0;Doses of 0.1 to 0.2 mg/kg of lorazepam administered over several minutes usually work well, and sometimes&#x000a0;higher doses are required to stop the seizure. If the seizure persists, there is no upper limit to the dose of the benzodiazepine (despite a decreased effectiveness over time). Still, it is vital to monitor the patient for hypotension or respiratory depression.</p>
        <p>The current American Epilepsy Society Guidelines published in 2016 show 3 choices for second-line therapy, including fosphenytoin, levetiracetam, and valproic acid. There is no evidence that&#x000a0;1 is superior to the others; however, valproic acid has the highest level of evidence.<xref ref-type="bibr" rid="article-28838.r8">[8]</xref>&#x000a0;Phenytoin is&#x000a0;1 of the most widely used anti-seizure medications, classically used as the drug of second choice to end an active seizure. Its use is typically when high doses of benzodiazepines have failed to stop the seizure activity. The initial recommended dose is 20 mg/kg intravenously. However, great caution is required when administering intravenous phenytoin as it can cause arrhythmias, hypotension, and even cardiac arrest if the dose is greater than 50 mg per minute. The patient must be monitored during the intravenous infusion. Purple glove syndrome is a rare side effect and can be avoided by limiting infusion rates to less than 25 mg per minute.<xref ref-type="bibr" rid="article-28838.r14">[14]</xref>&#x000a0;Fosphenytoin is a precursor of phenytoin and is safer than phenytoin as it does not contain the diluent propylene glycol. However, fosphenytoin is more expensive than phenytoin. Additionally, fosphenytoin can be administered intramuscularly, an advantage over phenytoin in patients without intravenous access. Valproic acid is a weak acid with high serum protein binding. Caution is important with a patient with liver and pancreatic disease. Contraindications include pregnant women with known teratogenic risk of spina bifida, low intelligence quotient, and autism in neonates.<xref ref-type="bibr" rid="article-28838.r15">[15]</xref>&#x000a0;Levetiracetam has the safest side effect profile and the least number of drug-drug interactions compared to the&#x000a0;3 above. It is bioavailable equally in oral and parenteral formulations. It is&#x000a0;excreted in urine mostly unchanged; thus, it requires dose adjustment in those with renal disease.</p>
        <p>
<bold>Management Following the End of the Seizures&#x000a0;</bold>
</p>
        <p>For those individuals who had a witnessed seizure and are now in the post-ictal phase, supportive care and seizure precautions are necessary. If the individual had low therapeutic levels of the seizure medications, then it may be appropriate to administer a loading dose in the emergency room before discharge. The reliability of anticonvulsant drug levels varies.<xref ref-type="bibr" rid="article-28838.r16">[16]</xref> The next step following seizure cessation is to look for seizure triggers, including toxic/metabolic, stroke, brain mass, iatrogenic, or newly diagnosed epilepsy. Routine blood count, basic metabolic panel, urine drug screen, and urine pregnancy test (when&#x000a0;indicated) are considerations for screening.&#x000a0;Cranial imaging is indispensable in identifying focal brain abnormalities. Magnetic resonance imaging is superior to conventional computerized tomography scans.<xref ref-type="bibr" rid="article-28838.r17">[17]</xref> Routine EEG has a high diagnostic value in the first 12 to 48 hours following seizure, approaching 53.1% versus 23.9%.<xref ref-type="bibr" rid="article-28838.r18">[18]</xref><xref ref-type="bibr" rid="article-28838.r19">[19]</xref><xref ref-type="bibr" rid="article-28838.r20">[20]</xref>. Sleep deprivation increases the yield of routine EEG by about 10%.<xref ref-type="bibr" rid="article-28838.r20">[20]</xref>&#x000a0;Lumbar puncture should be a diagnostic option in those with suspected meningoencephalitis.<xref ref-type="bibr" rid="article-28838.r21">[21]</xref> However, discharge&#x000a0;is only recommended if there are no other issues with the clinical presentation.</p>
      </sec>
      <sec id="article-28838.s4" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Individuals who have had&#x000a0;2 or more&#x000a0;unprovoked seizures over&#x000a0;24 hours&#x000a0;apart can be diagnosed with epilepsy. However, the current standard of care for a single unprovoked seizure is avoiding the triggers. Anticonvulsants are usually not recommended unless the individual has risk factors to endure recurrent seizures.<xref ref-type="bibr" rid="article-28838.r22">[22]</xref>&#x000a0;Current evidence does not support starting anti-seizure medications following a first seizure since it does not change the quality of life, although it lowers the risk for recurrence.<xref ref-type="bibr" rid="article-28838.r23">[23]</xref> However, these patients should see a neurologist within 15 days. Following new-onset seizure, patients are counseled about the following risk factors to facilitate the decision-making about starting anticonvulsants<xref ref-type="bibr" rid="article-28838.r21">[21]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p>Differential diagnosis of new-onset, seizure-like events includes migraine, TIA, syncope, and psychogenic events.</p>
          </list-item>
          <list-item>
            <p>Ancillary tests: Computed head topography studies are less sensitive than magnetic resonance brain imaging, with sensitivity reaching 30%. Commonly missed abnormalities include low-grade gliomas and hippocampal sclerosis. About 29% of patients with new-onset epilepsy have an abnormal electroencephalogram following their first routine (ie, 20-minute study) study.</p>
          </list-item>
          <list-item>
            <p>Discuss seizure triggers: Older data suggest that up to 30% of patients with suspected alcohol withdrawal seizures had a potentially epileptogenic structural abnormality related to a traumatic injury.</p>
          </list-item>
          <list-item>
            <p>Prolactin level can conditionally differentiate a convulsive seizure from a nonepileptic event; this requires measuring prolactin level 10 to 20 minutes after a suspected event compared with a baseline prolactin level collected at least 6 hours before the suspected event. Prolactin test cannot distinguish epileptic seizure from syncope</p>
          </list-item>
        </list>
        <p>Besides recurrent seizures, consider antiseizure therapy following a single seizure with either abnormal EEG with seizure tendency or abnormal MRI brain.<xref ref-type="bibr" rid="article-28838.r23">[23]</xref> A&#x000a0;close&#x000a0;follow-up with the primary care provider or the neurologist should be a priority. Before discharge, all patients must have their drug levels measured to ensure therapeutic levels and compliance. A seizure patient needs indefinite follow-up with a primary caregiver or a neurologist.</p>
      </sec>
      <sec id="article-28838.s5" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>
<bold>Outpatient Care</bold>
</p>
        <p>The decision to discharge patients following a seizure requires good clinical judgment.</p>
        <p>
<bold>Prevention</bold>
</p>
        <p>To date, there is no data to suggest that any intervention other than prescribed anti-seizure medications can prevent status epilepticus or recurrent seizures. Thus, the most important thing to emphasize to patients is medication compliance. The anti-seizure medication prescribed depends on the patient's underlying diagnosis, severity, pre-existing medications, other comorbidity, and potential for drug interactions. A consultation with a neurologist who oversees and directs the medication prescribed is necessary. Anytime a medication dose or frequency changes, it&#x000a0;should&#x000a0;be done in consultation with the neurologist.</p>
        <p>
<bold>Discontinuing Anticonvulsant Agents</bold>
</p>
        <p>To discontinue the anticonvulsant agent, the patient must be seizure-free for 2 to 5 years. Children usually outgrow their epileptic syndromes, and most do not require the use of antiseizure medications in adult life. The relapse rate in children is about 25%, whereas in adults it varies from 40% to 60%. This difference is most likely due to the different epileptic syndromes present in the&#x000a0;2 populations. Almost 75% of seizure relapses occur within the first 12 months after discontinuation of the medication. About 50% of patients have a seizure within the first 12 weeks. It is, therefore, critical to educate patients on seizure precautions during the first 3 months after discontinuation of medications; this means absolutely no driving, and the Department of Motor Vehicles (DMV) might need to be informed. There are no formal guidelines for discontinuation of antiseizure drugs, and roughly done over 8 to 24 weeks. A slower titration recommended for particular drugs such as carbamazepine, oxcarbazepine, phenobarbital, primidone, and benzodiazepines. Before discontinuing anti-seizure medications, it is important to know the risk factors for seizures. A normal EEG and a brain MRI are indicators of a low risk of recurrence, but if the EEG shows focal abnormalities or the MRI brain reveals focal limbic or cortical abnormalities, then the risk of recurrence is higher. Other factors also associated with a high risk of seizure recurrence after discontinuing medication include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Having a history of tonic-clonic or atonic seizures is associated with a much higher risk than absence seizures</p>
          </list-item>
          <list-item>
            <p>Higher and increased frequency of seizures</p>
          </list-item>
          <list-item>
            <p>A long duration of epilepsy before seizure control</p>
          </list-item>
          <list-item>
            <p>A short duration of freedom in between seizures</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28838.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>While most patients in the emergency room are manageable without a neurological consultation, consider a neurology consult for&#x000a0;the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>If the patient meets the definition of status epilepticus, Status epilepticus is defined as 2 or more subsequent seizures without regaining consciousness or 30 minutes or more of continuous seizure activity.<xref ref-type="bibr" rid="article-28838.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="article-28838.r24">[24]</xref>Any patient with a known diagnosis of epilepsy who has a breakthrough seizure: Non-adherence with anticonvulsants is a leading cause of the emergence of breakthrough seizures.<xref ref-type="bibr" rid="article-28838.r25">[25]</xref> These patients may need medication change to prevent future seizures.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Prolonged postictal state:&#x000a0;Patients&#x000a0;are usually admitted to a telemetry floor with close monitoring and further workup.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28838.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28838&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28838">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28838/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28838">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28838.s8">
        <title>References</title>
        <ref id="article-28838.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>Predicting epileptic seizures from scalp EEG based on attractor state analysis.</article-title>
            <source>Comput Methods Programs Biomed</source>
            <year>2017</year>
            <month>May</month>
            <volume>143</volume>
            <fpage>75</fpage>
            <page-range>75-87</page-range>
            <pub-id pub-id-type="pmid">28391821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Niu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Epileptic Seizure Prediction Based on Permutation Entropy.</article-title>
            <source>Front Comput Neurosci</source>
            <year>2018</year>
            <volume>12</volume>
            <fpage>55</fpage>
            <pub-id pub-id-type="pmid">30072886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manuel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Feinstein</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Sports participation for young athletes with medical conditions: Seizure disorder, infections and single organs.</article-title>
            <source>Curr Probl Pediatr Adolesc Health Care</source>
            <year>2018</year>
            <month>May</month>
            <volume>48</volume>
            <issue>5-6</issue>
            <fpage>161</fpage>
            <page-range>161-171</page-range>
            <pub-id pub-id-type="pmid">30017601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brna</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Woolridge</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dooley</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Perceived need for restrictions on activity for children with epilepsy.</article-title>
            <source>Epilepsy Behav</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>73</volume>
            <fpage>236</fpage>
            <page-range>236-239</page-range>
            <pub-id pub-id-type="pmid">28658653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pauschek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bernhard</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Syrbe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nickel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Neininger</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Merkenschlager</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kiess</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bertsche</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bertsche</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Epilepsy in children and adolescents: Disease concepts, practical knowledge, and coping.</article-title>
            <source>Epilepsy Behav</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>59</volume>
            <fpage>77</fpage>
            <page-range>77-82</page-range>
            <pub-id pub-id-type="pmid">27116534</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kralj-Hans</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Noble</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Landau</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Magill</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>McCrone</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ridsdale</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Self-Management education for adults with poorly controlled epILEpsy (SMILE (UK)): a randomised controlled trial protocol.</article-title>
            <source>BMC Neurol</source>
            <year>2014</year>
            <month>Apr</month>
            <day>03</day>
            <volume>14</volume>
            <fpage>69</fpage>
            <pub-id pub-id-type="pmid">24694207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bandino</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Garfinkle</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Zickefoose</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Hsieh</surname>
                <given-names>DT</given-names>
              </name>
            </person-group>
            <article-title>Epilepsy at a summer camp for children and young adults with developmental disabilities: a 3-year experience.</article-title>
            <source>Mil Med</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>179</volume>
            <issue>1</issue>
            <fpage>105</fpage>
            <page-range>105-10</page-range>
            <pub-id pub-id-type="pmid">24402994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glauser</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shinnar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gloss</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alldredge</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Arya</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bainbridge</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bare</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bleck</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dodson</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Garrity</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jagoda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lowenstein</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pellock</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Riviello</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sloan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Treiman</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.</article-title>
            <source>Epilepsy Curr</source>
            <year>2016</year>
            <season>Jan-Feb</season>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-61</page-range>
            <pub-id pub-id-type="pmid">26900382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mollao&#x0011f;lu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bolayir</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Injuries in Patients with Epilepsy and Some Factors Associated with Injury.</article-title>
            <source>Noro Psikiyatr Ars</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>50</volume>
            <issue>3</issue>
            <fpage>269</fpage>
            <page-range>269-273</page-range>
            <pub-id pub-id-type="pmid">28360554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shafer</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Buelow</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Noe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shinnar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dewar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Levisohn</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Dean</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ficker</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pugh</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Barkley</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>A consensus-based approach to patient safety in epilepsy monitoring units: recommendations for preferred practices.</article-title>
            <source>Epilepsy Behav</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>449</fpage>
            <page-range>449-56</page-range>
            <pub-id pub-id-type="pmid">22999858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clore</surname>
                <given-names>ET</given-names>
              </name>
            </person-group>
            <article-title>Seizure precautions for pediatric bedside nurses.</article-title>
            <source>Pediatr Nurs</source>
            <year>2010</year>
            <season>Jul-Aug</season>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>191</fpage>
            <page-range>191-4; quiz 195</page-range>
            <pub-id pub-id-type="pmid">20860258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buelow</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Privitera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Levisohn</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barkley</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>A description of current practice in epilepsy monitoring units.</article-title>
            <source>Epilepsy Behav</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>308</fpage>
            <page-range>308-13</page-range>
            <pub-id pub-id-type="pmid">19362601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kanner</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ashman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gloss</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Harden</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bourgeois</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bautista</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Abou-Khalil</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Burakgazi-Dalkilic</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Llanas Park</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hirtz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nespeca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gidal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Faught</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.</article-title>
            <source>Neurology</source>
            <year>2018</year>
            <month>Jul</month>
            <day>10</day>
            <volume>91</volume>
            <issue>2</issue>
            <fpage>74</fpage>
            <page-range>74-81</page-range>
            <pub-id pub-id-type="pmid">29898971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okogbaa</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Onor</surname>
                <given-names>IO</given-names>
              </name>
              <name>
                <surname>Arije</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Lillis</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Phenytoin-Induced Purple Glove Syndrome: A Case Report and Review of the Literature.</article-title>
            <source>Hosp Pharm</source>
            <year>2015</year>
            <month>May</month>
            <volume>50</volume>
            <issue>5</issue>
            <fpage>391</fpage>
            <page-range>391-5</page-range>
            <pub-id pub-id-type="pmid">26405326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tomson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Battino</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bonizzoni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lindhout</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Perucca</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sabers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Vajda</surname>
                <given-names>F</given-names>
              </name>
              <collab>EURAP Study Group</collab>
            </person-group>
            <article-title>Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.</article-title>
            <source>Neurology</source>
            <year>2015</year>
            <month>Sep</month>
            <day>08</day>
            <volume>85</volume>
            <issue>10</issue>
            <fpage>866</fpage>
            <page-range>866-72</page-range>
            <pub-id pub-id-type="pmid">26085607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>St Louis</surname>
                <given-names>EK</given-names>
              </name>
            </person-group>
            <article-title>Monitoring antiepileptic drugs: a level-headed approach.</article-title>
            <source>Curr Neuropharmacol</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>115</fpage>
            <page-range>115-9</page-range>
            <pub-id pub-id-type="pmid">19949569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lawn</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bynevelt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dunne</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Neuroimaging of first-ever seizure: Contribution of MRI if CT is normal.</article-title>
            <source>Neurol Clin Pract</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>398</fpage>
            <page-range>398-403</page-range>
            <pub-id pub-id-type="pmid">29473604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paliwal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wakerley</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Yeo</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Ibrahim</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Wilder-Smith</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sim</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Pohlmann-Eden</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rathakrishnan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Early electroencephalography in patients with Emergency Room diagnoses of suspected new-onset seizures: Diagnostic yield and impact on clinical decision-making.</article-title>
            <source>Seizure</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>31</volume>
            <fpage>22</fpage>
            <page-range>22-6</page-range>
            <pub-id pub-id-type="pmid">26362373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sofat</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Teter</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kavak</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Time interval providing highest yield for initial EEG in patients with new onset seizures.</article-title>
            <source>Epilepsy Res</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>127</volume>
            <fpage>229</fpage>
            <page-range>229-232</page-range>
            <pub-id pub-id-type="pmid">27639127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Debicki</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Electroencephalography after a single unprovoked seizure.</article-title>
            <source>Seizure</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>49</volume>
            <fpage>69</fpage>
            <page-range>69-73</page-range>
            <pub-id pub-id-type="pmid">28532713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gavvala</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Schuele</surname>
                <given-names>SU</given-names>
              </name>
            </person-group>
            <article-title>New-Onset Seizure in Adults and Adolescents: A Review.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Dec</month>
            <day>27</day>
            <volume>316</volume>
            <issue>24</issue>
            <fpage>2657</fpage>
            <page-range>2657-2668</page-range>
            <pub-id pub-id-type="pmid">28027373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertsche</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dahse</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Neininger</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Bernhard</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Syrbe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Frontini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kiess</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Merkenschlager</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bertsche</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Ambulatory care of children treated with anticonvulsants - pitfalls after discharge from hospital.</article-title>
            <source>Klin Padiatr</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>225</volume>
            <issue>5</issue>
            <fpage>277</fpage>
            <page-range>277-82</page-range>
            <pub-id pub-id-type="pmid">23946090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tao</surname>
                <given-names>JX</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Management of an Unprovoked First Seizure in Adults.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Oct</month>
            <day>18</day>
            <volume>316</volume>
            <issue>15</issue>
            <fpage>1590</fpage>
            <page-range>1590-1591</page-range>
            <pub-id pub-id-type="pmid">27755622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glauser</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Designing practical evidence-based treatment plans for children with prolonged seizures and status epilepticus.</article-title>
            <source>J Child Neurol</source>
            <year>2007</year>
            <month>May</month>
            <volume>22</volume>
            <issue>5 Suppl</issue>
            <fpage>38S</fpage>
            <page-range>38S-46S</page-range>
            <pub-id pub-id-type="pmid">17690086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28838.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brodtkorb</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Samsonsen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sund</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Br&#x000e5;then</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Helde</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Reimers</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Treatment non-adherence in pseudo-refractory epilepsy.</article-title>
            <source>Epilepsy Res</source>
            <year>2016</year>
            <month>May</month>
            <volume>122</volume>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">26897547</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
